Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Cancer_Cell
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Cancer_Cell
-
Prikvačeni tweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Online Now: EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibitionhttp://dlvr.it/RP5315
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Online Now: THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cellshttp://dlvr.it/RP4HZQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Look for Scientific Editor
@Krista_Bledsoe at#KScancerepigenetics#KSgene to talk about your researchhttps://twitter.com/Krista_Bledsoe/status/1221418954092171264 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RT
@AICancer2020 Looking forward to this exciting conference. Register soon for discounted delegate fees.https://twitter.com/AICancer2020/status/1221872628882903040 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Cell proslijedio/la je Tweet
This is our cells under pressure.. Thanks for this insightful Previews of our work on
@Cancer_Cell https://www.cell.com/cancer-cell/fulltext/S1535-6108(19)30575-6 …@Albert0Bardelli@fdinicolantonio@sciencemagazine@fpoirccs@AIRC_itHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An exciting opportunity to join the editorial team at our sister journal
@MolecularCellhttps://twitter.com/MolecularCell/status/1220878003699429377 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Cancer Cell proslijedio/la je Tweet
So proud of Dr. Dhivya Sudhan on the publication of her manuscript in
@Cancer_Cell! Also my first (co) corresponding authorship. Dhivya found that activation of the mTOR pathway drives resistance to#neratinib in#HER2-mutant cancers. Tweetorial below https://www.cell.com/cancer-cell/fulltext/S1535-6108(19)30583-5 …pic.twitter.com/HHNFrGsjE0
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Online Now: Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancershttp://dlvr.it/RNdhyy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Online Now: Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancerhttp://dlvr.it/RNd0xG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Scientific Editor Montse Rojo de la Vega is at
@KeystoneSymp#KS1Mgenome at Breckenridge, CO. She will be there all week, be sure to catch her to discuss these great talks!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Senior Editor Harmony Turk is excited for the start of
@KeystoneSymp#KScancerevol20 meeting in beautiful Banff.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Cell proslijedio/la je Tweet
More cool work from the Janne lab
@DanaFarber figuring out the vulnerabilities of dormant EGFR-mutant NSCLC on TKI. Inhibiting MEK plus YAP/TEAD tips these surviving cells into apoptosis! https://www.cell.com/cancer-cell/fulltext/S1535-6108(19)30576-8 …pic.twitter.com/cER9JIiG3r
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Cell proslijedio/la je Tweet
Recent exciting papers by the
@gclab1 place the focus on the epichaperome, the ability to image it and its use as a therapy target in tumors as also@nkourtis has shown in my lab for T-ALL.@Cancer_Cellhttps://www.sciencedirect.com/science/article/pii/S1535610819304271 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Senesce to Survive: YAP-Mediated Dormancy Escapes EGFR/MEK Inhibition http://dlvr.it/RN5QY2 pic.twitter.com/Fz8KpVmuGZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sticking it to KRAS: Covalent Inhibitors Enter the Clinichttp://dlvr.it/RN57xq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This Is Our Cells Under Pressure: Decreased DNA Damage Repair in Response to Targeted Therapies Facilitates the Emergence of Drug-Resistant Clones http://dlvr.it/RN3LYp pic.twitter.com/iPhO8VcbFr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Genome Evolutionary Trajectories in Metastasishttp://dlvr.it/RN2cxs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidateshttp://dlvr.it/RN2JFB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Cell proslijedio/la je Tweet
Thanks
@Krista_Bledsoe for visiting@sloan_kettering to tell us about her unique role as editor@Cancer_Cell and@MolecularCell@CellCellPress!pic.twitter.com/z8pSTA5b1K
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.